These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35943136)

  • 1. In vitro killing of multidrug/extensively drug-resistant
    Slade-Vitković M; Bedenić B; Bielen L; Batarilo I; Kibel S; Maravić-Vlahoviček G
    J Chemother; 2023 May; 35(3):219-230. PubMed ID: 35943136
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa.
    Avery LM; Sutherland CA; Nicolau DP
    J Med Microbiol; 2019 Jun; 68(6):893-897. PubMed ID: 31050629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa.
    Papp-Wallace KM; Zeiser ET; Becka SA; Park S; Wilson BM; Winkler ML; D'Souza R; Singh I; Sutton G; Fouts DE; Chen L; Kreiswirth BN; Ellis-Grosse EJ; Drusano GL; Perlin DS; Bonomo RA
    J Infect Dis; 2019 Jul; 220(4):666-676. PubMed ID: 31099835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.
    Falagas ME; Kastoris AC; Karageorgopoulos DE; Rafailidis PI
    Int J Antimicrob Agents; 2009 Aug; 34(2):111-20. PubMed ID: 19403273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of
    Suich J; Mawer D; van der Woude M; Wearmouth D; Burns P; Smeets T; Barlow G
    J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35476672
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.
    Kastoris AC; Rafailidis PI; Vouloumanou EK; Gkegkes ID; Falagas ME
    Eur J Clin Pharmacol; 2010 Apr; 66(4):359-68. PubMed ID: 20186407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of
    Mataraci Kara E; Yilmaz M; İstanbullu Tosun A; Özbek Çelik B
    Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F; Quentin C
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa.
    Walsh CC; McIntosh MP; Peleg AY; Kirkpatrick CM; Bergen PJ
    J Antimicrob Chemother; 2015 Nov; 70(11):3042-50. PubMed ID: 26209311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vitro interaction of fosfomycin and meropenem against metallo-β-lactamase-producing
    Jahan S; Davis H; Ashcraft DS; Pankey GA
    J Investig Med; 2021 Feb; 69(2):371-376. PubMed ID: 33122248
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase.
    Albiero J; Mazucheli J; Barros JPDR; Szczerepa MMDA; Nishiyama SAB; Carrara-Marroni FE; Sy S; Fidler M; Sy SKB; Tognim MCB
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
    Walsh CC; Landersdorfer CB; McIntosh MP; Peleg AY; Hirsch EB; Kirkpatrick CM; Bergen PJ
    J Antimicrob Chemother; 2016 Aug; 71(8):2218-29. PubMed ID: 27118778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Antibiofilm Activity of Fosfomycin Alone and in Combination with Other Antibiotics against Multidrug-Resistant and Extensively Drug-Resistant
    Slade-Vitković M; Batarilo I; Bielen L; Maravić-Vlahoviček G; Bedenić B
    Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa.
    Santos DA; Nascimento MM; Vitali LH; Martinez R
    Rev Soc Bras Med Trop; 2013; 46(3):299-303. PubMed ID: 23856877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa.
    Cuba GT; Rocha-Santos G; Cayô R; Streling AP; Nodari CS; Gales AC; Pignatari ACC; Nicolau DP; Kiffer CRV
    J Antimicrob Chemother; 2020 Jul; 75(7):1874-1878. PubMed ID: 32240299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
    Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J
    Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli].
    Adaleti R; Nakipoğlu Y; Arıcı N; Kansak N; Çalık Ş; Şenbayrak S; Balık R; Aksaray S
    Mikrobiyol Bul; 2023 Jul; 57(3):365-377. PubMed ID: 37462301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.